![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania
The G protein β5 subunit differs from other β subunits in having divergent sequence and subcellular localization patterns. Although β5
2 modulates effectors, β5 associates with R7 family regulators of G protein signaling (RGS) proteins when purified from tissues. To investigate β5 complex formation in vivo, we used multicolor bimolecular fluorescence complementation in human embryonic kidney 293 cells to compare the abilities of 7
subunits and RGS7 to compete for interaction with β5. Among the
subunits, β5 interacted preferentially with
2, followed by
7, and efficacy of phospholipase C-β2 activation correlated with amount of β5
complex formation. β5 also slightly preferred
2 over RGS7. In the presence of coexpressed R7 family binding protein (R7BP), β5 interacted similarly with
2 and RGS7. Moreover,
2 interacted preferentially with β1 rather than β5. These results suggest that multiple coexpressed proteins influence β5 complex formation. Fluorescent β5
2 labeled discrete intracellular structures including the endoplasmic reticulum and Golgi apparatus, whereas β5RGS7 stained the cytoplasm diffusely. Coexpression of
o targeted both β5 complexes to the plasma membrane, and
q also targeted β5
2 to the plasma membrane. The constitutively activated
o mutant,
oR179C, produced greater targeting of β5RGS7 and less of β5
2 than did
o. These results suggest that
o may cycle between interactions with β5
2 or other β
complexes when inactive, and β5RGS7 when active. Moreover, the ability of β5
2 to be targeted to the plasma membrane by
subunits suggests that functional β5
2 complexes can form in intact cells and mediate signaling by G protein-coupled receptors.
Address correspondence to: Catherine Berlot, Weis Center for Research, Geisinger Clinic, 100 North Academy Avenue, Danville, PA 17822-2623. E-mail: chberlot{at}geisinger.edu
Related articles in MolPharm:
5 Signaling
This article has been cited by other articles:
![]() |
C. E. Zeller and H. G. Dohlman Illuminating Gbeta5 Signaling Mol. Pharmacol., October 1, 2007; 72(4): 810 - 811. [Abstract] [Full Text] [PDF] |
||||